{"id":"W4411857643","doi":"10.1093/oncolo/oyaf194","title":"Mitigation and management of adverse events associated with amivantamab therapy","year":2025,"lang":"en","type":"review","venue":"The Oncologist","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Johnson and Johnson","keywords":"Medicine; Erlotinib; Adverse effect; Rash; Oncology; Internal medicine; Epidermal growth factor receptor; Hypoalbuminemia; Chemotherapy; Paronychia; Gefitinib; Targeted therapy; Cancer; Dermatology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001138543,0.0001489208,0.0005976561,0.00004823863,0.00006116831,0.000001619987,0.00006666674,0.00007896232,0.00001854046],"category_scores_gemma":[0.00001153342,0.00007041929,0.00009531339,0.0001982355,0.00009782716,0.00001433367,0.00002698957,0.00008816962,0.000001643742],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002655798,"about_ca_system_score_gemma":0.0002372257,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002479394,"about_ca_topic_score_gemma":0.0000152454,"domain_scores_codex":[0.9993563,0.00007761645,0.0002038719,0.0001484345,0.000123534,0.00009019872],"domain_scores_gemma":[0.9993545,0.0001334068,0.0002479207,0.0001992212,0.00004214633,0.0000228328],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00005155989,0.0002812303,0.0002544947,0.006388614,0.003147077,0.00003200529,0.00007125898,7.60736e-7,7.041e-8,0.0003618098,0.0003356321,0.9890755],"study_design_scores_gemma":[0.004852723,0.001073059,0.01133484,0.05800011,0.01563062,0.00002117469,0.0002424453,0.000002028922,0.000001763494,0.0001072634,0.9085307,0.0002033203],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002698176,0.9834701,0.00001157223,0.000170969,0.0000708427,0.002038489,0.00005411862,0.00002358009,0.01389053],"genre_scores_gemma":[0.0005198895,0.9928262,0.0001677911,0.00006260178,0.00001440516,0.0002245826,0.0002376206,0.00001105763,0.00593588],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9888722,"threshold_uncertainty_score":0.2871615,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03691692597764053,"score_gpt":0.4025874823463018,"score_spread":0.3656705563686612,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}